Heng-Yi Liu

Genome-Informed Targeted Therapy for Osteosarcoma.

Marcus R. Breese, Krystal M. Straessler, F. Hazard, 2018, Cancer discovery.

Title: Genome-Informed Targeted Therapy for Osteosarcoma Running title: Genome-Informed Targeted Therapy for Osteosarcoma

Krystal M. Straessler, Bogdan Tanasa, S. Spunt, 2018 .

Comparative Tumor RNA Sequencing Analysis for Difficult-to-Treat Pediatric and Young Adult Patients With Cancer

David Haussler, Jingchun Zhu, Katrina Learned, 2019, JAMA network open.

Development and characterization of new patient-derived xenograft (PDX) models of osteosarcoma with distinct metastatic capacities

Marcus R. Breese, F. Hazard, M. Sirota, 2023, bioRxiv.

A Comprehensive Circulating Tumor DNA Assay for Detection of Translocation and Copy-Number Changes in Pediatric Sarcomas

Ash A. Alizadeh, Krystal M. Straessler, F. Hazard, 2021, Molecular Cancer Therapeutics.

Comprehensive analysis reveals CCDC60 as a potential biomarker correlated with prognosis and immune infiltration of head and neck squamous cell carcinoma

Heng-Yi Liu, Zhixin Liu, Tianhe Fang, 2023, Frontiers in Oncology.

Osteosarcoma PDX-Derived Cell Line Models for Preclinical Drug Evaluation Demonstrate Metastasis Inhibition by Dinaciclib through a Genome-Targeted Approach

Marcus R. Breese, F. Hazard, L. Sayles, 2023, Clinical cancer research : an official journal of the American Association for Cancer Research.